Sleep Apnea Diagnostic System Market

Polysomnography Devices Highly Sought-after in Sleep Apnea Diagnosis

Polysomnography devices remain the most preferred sleep apnea diagnostic system in global market. These devices comprise ambulatory and clinic polysomnography, and help in the diagnosis of sleep apnea by evaluating multiple parameters such as heart rate, breathing rate, eye and leg movements, patient’s brain waves, and blood oxygen level.

Most widely adopted by hospitals and sleep centers, polysomnography devices enable doctors to monitor varied parameters and get more comprehensive information about sleep disorders.

Growth of the Market in Emerging Economies

Increasing prevalence of sleep apnea owing to rise in cardiovascular diseases, diabetes and other diseases in the Asia Pacific region are factors offering a strong impetus to the growth of the sleep apnea diagnostic system market.

The launch of advanced technological devices prominently accounts for the growing popularity of sleep apnea diagnostic system across developing regional markets. Consistent rise in the number of manufacturers and distributors, is likely to contribute to the growth of the sleep apnea diagnostic system market in the near future.

SLEEP APNEA DIAGNOSTIC SYSTEM MARKET STRUCTURE ANALYSIS

• Key players continue to increase the market share with the launch of new products in the market.
• Joint ventures and partnership with distributors are the strategic actions practised by majority of key players.
• Prominent players continue to address the unmet needs in the market through inorganic strategies, such as mergers and acquisitions.
• The sleep apnea diagnostic system market has been relatively moderate in size and likely to remain dynamic, growing in steady pace throughout the forecast period.
• Major players focus on inorganic growth strategies to make a strong hold on targeted in-licensing and acquisitions through expanding its R&D activities and its distribution channels particularly including its specialist retail chains.

FREQUENTLY ASKED QUESTIONS ABOUT SLEEP APNEA DIAGNOSTIC SYSTEM MARKET

Which region is expected to lead in terms of revenue in sleep apnea diagnostic market?

North America remains most lucrative region in terms of revenue and is anticipated to grow at an impressive rate during the forecast period. India, China, and Brazil are expected to be targeted geographies for incremental opportunity for regional and major players. Increasing prevalence of sleep apnea and increase in government initiatives towards growing awareness regarding sleeping disorders are the major factors contributing the growth of market

Which product segment would be most attractive for investments?

Polysomnography devices segment remain the most preferred product type in the global sleep apnea diagnostic system market. Polysomnography devices comprise of ambulatory and clinic polysomnography.

These devices help in the diagnosis of sleep apnea by evaluating multiple parameters such as heart rate, breathing rate, eye and leg movements, patient’s brain waves, blood oxygen level etc.  Polysomnography devices are most commonly used in hospitals and sleep centers. Polysomnography devices enable doctors to monitor varied parameters and get more comprehensive information about disorders.

Which end users would contribute maximum revenue during the forecast period?

In terms of end user, sleep centers and clinics will continue to be prominent end user for sleep apnea diagnostic system. This is attributed to the increasing preferences among patients to visit sleep centers and clinics. Moreover, sleep centers and clinics are well equipped with modern devices and medical settings required for the diagnosis of sleep apnea.

Who are the major players in the lacrimal duct stent tube market?

Koninklijke Philips N.V and ResMed Inc. among the leading market players in the sleep apnea diagnostic system market. These manufacturers continue to dominate the market landscape of the sleep apnea diagnostic system market due to its focus on product innovation, market leadership in product introduction, and strong distribution network with hospitals and sleep centers and clinics to increase sales.

Which are the drivers responsible for the market growth?

Growth in the sedentary life style, increase in obese population associated with increased risk of cardiovascular diseases and increasing prevalence of obstructive sleep apnea are the primary factors for the growth of sleep apnea diagnostic system market. Moreover, technological advancements for better diagnosis and management of sleep apnea have been the driving factors for the growth of the sleep apnea diagnostic system market

Boost in Sales at Sleep Centers, Clinics, and Home Care Settings

Adoption of sleep apnea diagnostic systems remains maximum at sleep centers and clinics that collectively hold nearly 25% of market value. However, Future Market Insights (FMI) observes rapid transition of the sleep testing services market from in-lab testing to home sleep apnea testing - driven by high price point of the former. Sleep apnea diagnostic systems are also witnessing impressive traction at home care settings.

North America’s Market to Exceed ~US$ 4 Bn by 2029 End

Currently a ~US$ 2 Bn market, North America will sustain its primacy in global sleep apnea diagnostic system market over the next decade. The U.S. represents leading market owing to increasing prevalence of sleep-related disorders, which is complemented by the favorable reimbursement policy framework.

Moreover, Wester European countries are developing lucrative markets for sleep apnea diagnostic system manufacturers. Asian countries also store ample potential opportunities, particularly for home sleep testing (HST) devices, owing to cost efficiency.

HST Systems Hold Measurable Profits

In-lab testing is an expensive procedure due to costs associated with equipment and nursing services. Patients are showing higher preference for cost-effective home sleep testing services with the help of home sleep screening devices, which are ideal for home-bound elderly. In addition, reimbursement companies adopt more favorable policies towards HST over in-lab testing. Manufacturers, therefore, are focusing on the development of wearables sleep trackers and wireless screening devices.

How Growth will Unfold

Polysomnography (PSG) devices are highly preferred systems for sleep apnea diagnosis, especially in developed regions. Although clinical PSG monitoring devices are leading the way, noteworthy traction for ambulatory PSG monitoring devices has been observed. On the other hand, rising inclination towards home care settings and innovative recording systems is paving the way for sleep apnea screening devices and actigraphy monitoring devices.

Actigraphy monitoring devices will surpass PSG devices by 2020 end, on the back of their non-invasive nature and wearability. Despite slower adoption, peripheral capillary oxygen saturation (SPO2) will record a larger share as compared to that of nasal flow sensors.

SLEEP APNEA DIAGNOSTIC SYSTEM MARKET TAXONOMY

The global sleep apnea diagnostic system is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

• Polysomnography (PSG) Devices
  • Ambulatory PSG Monitoring Devices
  • Clinical PSG Monitoring Devices
• Sleep Apnea Screening Devices
  • Nasal Flow Sensors
  • Peripheral Capillary Oxygen Saturation (SPO2)
• Actigraphy Monitoring Devices

End User

• Home Care Settings
• Hospitals
• Sleep Centers and Clinics

Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• Japan
• Middle East & Africa